Raphael Colle - Publications

Troponin Screening and Major Cardiovascular Adverse Events During Immune Checkpoint Inhibitor Therapy.

Journal: JAMA network open

Published: July 21, 2026

Endomyocardial Biopsy in Suspected Immune Checkpoint Inhibitor-Myocarditis: Histologic Spectrum and Correlations With Clinical and Cardiac Magnetic Resonance Features.

Journal: Journal of the American Heart Association

Published: June 23, 2026

Dual CTLA-4/PD-1 Blockade Versus Anti-PD-1 in MSI-H Metastatic Colorectal Cancer: Early Survival Benefit and Exploratory Clinical Predictors.

Journal: Clinical colorectal cancer

Published: January 06, 2026

Antiangiogenic therapy for advanced biliary tract cancers: promising or illusory?

Journal: Journal of gastrointestinal oncology

Published: November 16, 2025

Neoadjuvant pembrolizumab with a watch‑and‑wait strategy for localized MSI/dMMR colon cancer: Study protocol for a randomized GERCOR 109 - PRODIGE 84 phase II trial (PREMICES).

Journal: Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver

Published: October 31, 2025

Cardiovascular safety of a standardized outpatient triage and diagnostic approach for suspected cardiovascular immune-related adverse events of immune checkpoint inhibitors.

Journal: Archives of cardiovascular diseases

Published: March 07, 2025

Nanoliposomal irinotecan in advanced biliary tract cancers.

Journal: The lancet. Gastroenterology & hepatology

Published: May 03, 2024

Investigation of a Mycobacterium fortuitum catheter-related bloodstream infection in an oncology unit.

Journal: Infection control and hospital epidemiology

Published: February 21, 2023

BRAF V600E/RAS Mutations and Lynch Syndrome in Patients With MSI-H/dMMR Metastatic Colorectal Cancer Treated With Immune Checkpoint Inhibitors.

Journal: The oncologist

Published: January 11, 2023

Prognostic impact of performance status on the outcomes of immune checkpoint inhibition strategies in patients with dMMR/MSI-H metastatic colorectal cancer.

Journal: European journal of cancer (Oxford, England : 1990)

Published: February 25, 2022

Ascites and resistance to immune checkpoint inhibition in dMMR/MSI-H metastatic colorectal and gastric cancers.

Journal: Journal for immunotherapy of cancer

Published: January 06, 2022

Treatments after Immune Checkpoint Inhibitors in Patients with dMMR/MSI Metastatic Colorectal Cancer.

Journal: Cancers

Published: December 23, 2021